Chemoinformaics analysis of 7-HYDROXYQUINOLINE
| Molecular Weight | 145.161 | nRot | 0 |
| Heavy Atom Molecular Weight | 138.105 | nRig | 11 |
| Exact Molecular Weight | 145.053 | nRing | 2 |
| Solubility: LogS | -2.112 | nHRing | 1 |
| Solubility: LogP | 1.615 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 21.5996 |
| nHD | 1 | BPOL | 8.16245 |
| QED | 0.614 |
| Synth | 1.804 |
| Natural Product Likeliness | -0.162 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.006 |
| HIA | 0.014 |
| CACO-2 | -4.481 |
| MDCK | 0.0000256 |
| BBB | 0.195 |
| PPB | 0.639558 |
| VDSS | 1.661 |
| FU | 0.278223 |
| CYP1A2-inh | 0.952 |
| CYP1A2-sub | 0.443 |
| CYP2c19-inh | 0.307 |
| CYP2c19-sub | 0.151 |
| CYP2c9-inh | 0.073 |
| CYP2c9-sub | 0.906 |
| CYP2d6-inh | 0.261 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.102 |
| CYP3a4-sub | 0.186 |
| CL | 11.761 |
| T12 | 0.73 |
| hERG | 0.038 |
| Ames | 0.332 |
| ROA | 0.745 |
| SkinSen | 0.842 |
| Carcinogencity | 0.53 |
| EI | 0.99 |
| Respiratory | 0.915 |
| NR-Aromatase | 0.126 |
| Antiviral | No |
| Prediction | 0.773967 |